For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
Also known as: tri-agonist, triple receptor agonist
A triple agonist is a single molecule engineered to activate three receptors at once. In incretin-class research this means simultaneous agonism at the GLP-1, GIP, and glucagon receptors.
Triple agonists build on dual agonists by adding glucagon-receptor (GCGR) activity to GLP-1R and GIPR engagement. All three are Gs-coupled class B GPCRs, so the shared cAMP output can be studied as an integrated signal in cell models.
Researchers use triple agonists to dissect how relative potency at each receptor shapes downstream signaling, comparing them against dual incretin-receptor agonists.
Related Products
Related Terms